In a proteomics project, differential PGRMC1 phosphorylation in estrogen receptor-positive and -negative breast cancer has been observed, indicating that not only the expression level but also PGRMC1's phosphorylation may play a role in breast cancer [35]. Here, PGRMC1 is linked to breast cancer.